First human test of novel brain cancer vaccine shows promise
Disease control
Completed
This study tested a new type of cancer vaccine called EO2401 in adults whose aggressive brain tumor (glioblastoma) had returned after standard treatment. The main goals were to check the vaccine's safety and see if it could trigger an immune response against the cancer. The vacci…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC